IPO Boutique Research, Color & More Information for Subscribers
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Independence Realty Trust Symbol: IRT Price: Last trade $10.61 Trade Date: 9/30 Shares: 25 million Underwriter(s)Citigroup Rating=Subscription Needed Company: Foamix Pharmaceuticals[…]
IPOBoutique is a full service syndicate boutique. We not only relay color and advisories on IPOs, but we rate every secondary that hits the tape on a nightly basis. We also provide a track record for secondary’s we have issued a ‘BUY’ rating to. Company: Alnylam
It’s Thursday, so why not indulge the ‘throw-back’ nature of the day and look at a pair of biotechs from January 2014 that started the Healthcare crazy in the IPO market: Dicerna Pharmaceuticals (Nasdaq: DRNA) and Ultragenyx Pharmaceuticals (Nasdaq: RARE). These were two of 102 biotech deals that came to market in 2014 but the[…]